BIZTRAC BETA
Wholesale of pharmaceutical and medical goods

RAYONEX BIOMEDICAL NORWAY AS

Org. no. 917746044 Limited company (AS) Tinn Incorporated 2016 Active
Ownership graph ↗
Revenue 2025 NOK 702,000
Operating profit NOK 95,000
Equity NOK 285,000
Incorporated 2016
Share capital NOK 30,000

RAYONEX BIOMEDICAL NORWAY AS is registered as a limited company in Tinn, Telemark with organisation number 917746044. The business is classified under wholesale of pharmaceutical and medical goods (NACE 46.460). The company was incorporated in 2016. Registered share capital is NOK 30,000, divided into 1000 shares. The company's stated purpose is: “Drive import salg av helserelaterte artikler/produkter. Behandlingsapparater. Samt egen klinikk med behandling av matintoleranser, og andre helseplager.”. The most recent filed accounts, for the 2025 financial year, show NOK 702,000 in revenue and NOK 95,000 in operating profit.

Key figures · 2025

Revenue
NOK 702,000
Operating profit
NOK 95,000
Equity
NOK 285,000
Est. value
NOK 487,000

Financial health · 2025

Liquidity
2.25
Very good
Current assets ÷ current liabilities
Profitability
Not available
Return on total assets
Solidity
81.6%
Very good
Equity as a share of total capital

Who owns RAYONEX BIOMEDICAL NORWAY AS?

JAN BJERKE
RAYONEX BIOMEDICAL NORWAY AS
NOK 702,000 rev. · NOK 95,000 profit

RAYONEX BIOMEDICAL NORWAY AS has 1 registered shareholder:

All shareholders and roles →

Frequently asked questions about RAYONEX BIOMEDICAL NORWAY AS

Who owns RAYONEX BIOMEDICAL NORWAY AS?

JAN BJERKE is the largest registered owner, with 100.0%.

What is the revenue of RAYONEX BIOMEDICAL NORWAY AS?

RAYONEX BIOMEDICAL NORWAY AS had revenue of NOK 702,000 in 2025.

Where is RAYONEX BIOMEDICAL NORWAY AS based?

RAYONEX BIOMEDICAL NORWAY AS has its business address in Rjukan.

Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.

Report a problem

Found a technical fault, or something wrong in the data? Tell us what happened.